2019 annual financial data

Entrada Therapeutics 2019 Net margin

Entrada Therapeutics 2019 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -11,824,000 USD and net income was -4,649,000 USD.
Operating cash flow was -10,801,000 USD.

Get free Entrada Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-11,824,000 USD
Net income
-4,649,000 USD
Operating cash flow
-10,801,000 USD